Your browser doesn't support javascript.
loading
Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphoma.
Song, Yuqin; Guo, Ye; Huang, Huiqiang; Li, Wei; Ke, Xiaoyan; Feng, Jifeng; Xu, Wei; Miao, Harry; Kinley, Judith; Song, Gregory; Dai, Yi; Wang, Hui; Zhu, Jun.
Afiliação
  • Song Y; Department of Clinical Oncology, Beijing Cancer Hospital, Beijing, China.
  • Guo Y; Department of Oncology, Shanghai East Hospital, Tongji University, Shanghai, China.
  • Huang H; Department of Medicine, Sun-Yat-sen University Cancer Center, Guangzhou, China.
  • Li W; Department of Oncology, The First Hospital of Jilin University, Changchun City, China.
  • Ke X; Department of Hematology, Peking University Third Hospital, Beijing, China.
  • Feng J; Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing, China.
  • Xu W; Department of Hematology, Jiangsu Province People's Hospital, Nanjing, China.
  • Miao H; Department of Clinical Oncology, Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Kinley J; Department of Clinical Oncology, Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Song G; Department of Clinical Oncology, Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Dai Y; Department of Clinical Oncology, Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Wang H; Department of Clinical Oncology, Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Zhu J; Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China.
Expert Rev Hematol ; 14(9): 867-875, 2021 09.
Article em En | MEDLINE | ID: mdl-34275403
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Linfoma Anaplásico de Células Grandes / Brentuximab Vedotin / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Expert Rev Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Linfoma Anaplásico de Células Grandes / Brentuximab Vedotin / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Expert Rev Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China